Company Data
Avalo Therapeutics Inc.
Ticker
AVTX
Current Price
$15.06 -3.71%
Market Cap
$278.8M
Price Target
Refer to Report
Volume
358.3K
52wk Range
$3.39 - $20.7199
Overview
Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006.